Skip to Content

Grant Support

Completed Grants

Hoffmann-LaRoche, Inc., “An open label prospective, pharmacokinetic/pharmacodynamics and safety evaluation of intravenous oseltamivir (Tamiflu ®) in the treatment of infants less than one year of age with influenza infection, protocol no. NP25138C” (2010-2013).  Boriosi, PI

Hoffmann-LaRoche, Inc., “An open label prospective, pharmacokinetic/pharmacodynamics and safety evaluation of intravenous oseltamivir (Tamiflu ®) in the treatment of children 1 to 12 years of age with influenza infection, protocol no. NP25139C” (2010-2013).  Boriosi, PI

NIH-NHLBl/UCLA, “Targeted genomic analysis of coagulation pathway in acute lung injury (ALI)” (2009-2013).  Boriosi, Co-Investigator

Isomark, LLC, “Changes in 13CO2/12CO2 delta” (2011-2012). Boriosi, PI

Hospira Pharmaceutical, “A phase III, randomized, double-blind, dose-controlled, multi-center study evaluating the safety and efficacy of dexmedetomidine in initially intubated and mechanically ventilated pediatric intensive care unit subjects” (2009-2011).  Boriosi, PI

Charlotte Coleman Frey Foundation, “Efficacy and safety of lung recruitment in pediatric patients with acute lung injury” (2006-2009). Boriosi, PI


Last updated: 07/29/2015
webmaster [at] pediatrics [dot] wisc [dot] edu
Copyright © 2015 The Board of Regents of the University of Wisconsin System